MedTrace Logo

Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity

NCT03492879 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2018-04-10

No results posted yet for this study

Summary

The aims of this study are to assess the performance of the non-invasive Electrical Impedance Technology (EIT) in evaluating the liver fibrosis stage in patients with chronic liver diseases, in comparisons with a liver biopsy and/or Shear wave elastography and Liver Ultrasonography.

The second aim is comparing between Liver Ultrasonography and Electrical Impedance Technology (EIT) to quantify the hepatic steatosis grade in patients with Non Alcoholic Fatty Liver Disease (NAFLD) .

Conditions

Interventions

DEVICE

EIT Technology

Electrical Impedance Technology is a non-invasive imaging method who is being tested for evaluation of liver fibrosis stage

Sponsors & Collaborators

  • Prof. Ziv Ben-Ari MD

    lead OTHER_GOV

Principal Investigators

  • Ziv Ben-Ari, MD · Sheba Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2019-05-15
Completion
2019-05-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03492879 on ClinicalTrials.gov